ORLANDO -- A gene therapy that could transform CAR T-cell treatment achieved rapid and potentially durable measurable ...

Hemophilia gene therapies arrived a few years ago with blockbuster expectations. But now, one therapy has been pulled from ...

Once limited to nonspecific anti-inflammatory therapies, expanding treatment options for atopic dermatitis are allowing therapy to be individualized.

The patchwork rollout of a gene therapy exposes weaknesses in the pricing and regulatory frameworks that determine who ...

Dr. Teresa Blankmeyer Burke is spending the fall semester in Florianópolis, a city in southern Brazil, to study the ethics of ...

Doctors explain why preventive treatment is replacing on-demand care in haemophilia, how early prophylaxis protects joints, ...

Adaptive workflow systems represent a significant departure from rigid, process-centric approaches. Instead of imposing a linear, step-by-step structure, teams will be able to dynamically assign and ...

Visakhapatnam: Centurion University of Technology and Management Andhra Pradesh held its 5th convocation ceremony on Saturday ...

On the proposal to reflect the Korean Bar Association's evaluations in judges' ratings, some said, "It is not desirable for the system to be hastily revamped in line with short-term or political ...

Discusses HOPE-3 Phase III Trial Results and Regulatory Path for Duchenne Muscular Dystrophy Therapy December 17, ...

The U.S. pharmaceutical industry in 2025 remains one of the nation’s most dynamic and profitable economic sectors.

Arnold closed Centaurus in 2012 to focus on philanthropy. Now, Arnold Ventures has $4.8bn in assets and awarded $200mn in grants in 2024, according to a tax document. Politically, Arnold has given to ...